Stay updated with breaking news from Totsuka. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. Food and Drug Administration announced the supplemental approval of Rexulti (brexpiprazole) oral tablets to treat agitation associated with dementia due to Alzheimer's disease.
Otsuka Holdings Co., Ltd. (OTCMKTS:OTSKF – Get Rating) was the target of a significant drop in short interest in April. As of April 30th, there was short interest totalling 254,700 shares, a drop of 44.8% from the April 15th total of 461,400 shares. Based on an average daily trading volume, of 400 shares, the days-to-cover […]
Otsuka Holdings Co., Ltd. (OTCMKTS:OTSKF – Get Rating) was down 3.8% on Monday . The company traded as low as $34.07 and last traded at $34.07. Approximately 500 shares changed hands during trading, a decline of 72% from the average daily volume of 1,760 shares. The stock had previously closed at $35.41. Otsuka Stock Performance […]
Shares of Otsuka Holdings Co., Ltd. (OTCMKTS:OTSKF – Get Rating) traded down 3.8% on Monday . The company traded as low as $34.07 and last traded at $34.07. 500 shares traded hands during trading, a decline of 72% from the average session volume of 1,760 shares. The stock had previously closed at $35.41. Otsuka Trading […]
Recommendation applies across England and Wales and the treatment is available now - News - PharmaTimes